Phospho-LAT (Y200) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your orders. Delivery timelines may vary based on the purchase method or your location. Please contact your local distributors for specific delivery details.
Synonyms
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
Target Names
LAT
Uniprot No.

Target Background

Function
Phospho-LAT (Y200) Antibody is essential for TCR (T-cell antigen receptor) and pre-TCR mediated signaling pathways, both in mature T-cells and during their development. It plays a critical role in FCGR3 (low affinity immunoglobulin gamma Fc region receptor III)-mediated signaling in natural killer cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. This antibody facilitates the coupling of receptor activation and their associated kinases to distal intracellular events, such as mobilization of intracellular calcium stores, PKC activation, MAPK activation, or cytoskeletal reorganization. It achieves this by recruiting PLCG1, GRB2, GRAP2, and other signaling molecules.
Gene References Into Functions
  1. Plasma membrane LAT activation precedes vesicular recruitment, defining two distinct phases of early T-cell activation. PMID: 29789604
  2. LAT1 overexpression is a negative prognostic marker associated with tumor grade, proliferating potential, and angiogenesis. It also mediates intracellular transport of anticancer agents. PMID: 28815339
  3. The dimerization-dependent, cooperative binding of the growth factor receptor-bound protein 2 family to LAT potentially increases antigen receptor sensitivity by reducing signalosome formation at incompletely phosphorylated LAT molecules. This prioritizes the formation of complete signalosomes. PMID: 28951535
  4. Nur77 suppresses CD4(+) T cell proliferation and reveals a suppressive role for Irf4 in TH2 polarization. Halving Irf4 gene-dosage leads to increases in GATA3(+) and IL-4(+) cells. PMID: 28538176
  5. LAT and phospholipase C-gamma dephosphorylation by SHP-1 inhibits natural killer cell cytotoxicity. PMID: 27221712
  6. Research has examined the molecular mobility within LAT:Grb2:SOS assemblies on supported membranes using single-molecule tracking. Trajectory analysis indicates a discrete temporal transition to subdiffusive motion below a characteristic timescale, suggesting that the LAT:Grb2:SOS assembly exhibits the dynamical structure of a loosely entangled polymer. PMID: 29045874
  7. Studies show that phosphotyrosine-mediated assembly of adaptor protein LAT networks produces two distinct kinetic species of the Ras activator SOS. PMID: 27370798
  8. Overexpression of LAT is linked to microcephaly. PMID: 28965845
  9. LAT and SLP-76 are randomly distributed throughout the clusters that form upon T cell receptor engagement. PMID: 27875277
  10. Research suggests that inherited LAT deficiency should be considered in patients with combined immunodeficiency presenting with T-cell abnormalities. PMID: 27522155
  11. This is the first documented case of a LAT-related disease in humans, manifesting as a progressive combined immune deficiency with severe autoimmune disease. PMID: 27242165
  12. Data indicate that LAT1 plays a significant role in regulating the uptake of essential amino acids, such as leucine, into endometrial cancer cells. The higher efficacy of BCH compared to LAT1 shRNA in inhibiting Ishikawa spheroid area suggests that other LAT family members may also contribute to cell growth. PMID: 27486861
  13. Research shows that the T cell-specific adaptor protein (TSAd) SH2 domain interacts with CD6 antigen and linker for activation of T cells protein (LAT) phosphotyrosine (pTyr) peptides. PMID: 27896837
  14. High expression of LAT1 and ASCT2 is correlated with metastasis and invasion in esophageal squamous cell carcinoma. PMID: 26936531
  15. IFT20 is crucial for delivering the intracellular pool of LAT to the immune synapse in naive primary T lymphocytes. PMID: 26715756
  16. Data show that the palmitoylation mutation of linker for activation of T cells (LAT) attenuates the signal transduction induced by glycosylphosphatidylinositol-anchored CD59 antigen in T cells. PMID: 26271970
  17. HSV-1-encoded Us3 protein disrupts TCR signaling and interleukin-2 production by inactivating the linker for activation of T cells. PMID: 25907557
  18. Patients with severe aplastic anemia exhibit increased levels of LAT and a disrupted Th1-Th2 balance. PMID: 24673455
  19. LAT acts as a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. PMID: 24204825
  20. Mutation of the palmitoylation site of LAT-EGFP attenuates the signal transduction of CD59 in T cells. PMID: 24200054
  21. Findings indicate that L-type amino acid transporter 1 is a primary transporter for essential amino acids into activated human T cells. PMID: 24038088
  22. Histone hypoacetylation on the LAT promoter inhibits LAT expression and enhances Th2 differentiation. Trichostatin A, a histone deacetylase inhibitor, promotes LAT expression and inhibits Th2 cytokine production. PMID: 23360572
  23. LAT is essential for maintaining calcium homeostasis in T cells. PMID: 22998346
  24. Research suggests a novel function and mechanism of TRAF6 action in the T cell receptor (TCR)-LAT signaling pathway, indicating that LAT also acts as an adapter in TCR/CD28-induced activation of TRAF6. PMID: 23514740
  25. LAT, located at the cell surface, can be efficiently recruited to activation-induced microclusters within seconds of T cell receptor (TCR) engagement. PMID: 23487428
  26. LAT cleavage may serve as a regulator of TCR-mediated activation of T-cells and not solely as a transducer of cell death-promoting stimuli. PMID: 23240581
  27. Expression of a constitutively active Raf transgene enhances lymphoproliferation, suggesting a role for the Ras-MAPK pathway in LAT-mediated autoimmune hyperproliferation. PMID: 22984075
  28. Nef employs a dual mechanism to disrupt early TCR signaling by limiting communication between LAT and SLP-76. PMID: 22802418
  29. Modeling and simulation of aggregation of membrane protein LAT with molecular variability in the number of binding sites for cytosolic Grb2-SOS1-Grb2. PMID: 22396725
  30. The segment comprising residues 112-126 of human LAT is required for its interaction with Lck. PMID: 22034845
  31. Activation of T cell antigen receptors leads to the recruitment and phosphorylation of linker for activation of T cells (Lat) from subsynaptic vesicles. Studies of Lat mutants confirm that recruitment precedes Lat phosphorylation. PMID: 21642986
  32. Data suggest that MAL regulates membrane order and the distribution of microtubule and transport vesicle docking machinery at the IS. This ensures correct protein sorting of Lck and LAT to the cSMAC. PMID: 21508261
  33. PECAM-1-mediated inhibition of GPVI-dependent platelet responses results from the recruitment of SHP-2-p85 complexes to tyrosine-phosphorylated PECAM-1, which diminishes the association of PI3K with activatory signaling molecules Gab1 and LAT. PMID: 20723025
  34. LAT recruits Src homology 2 domain-containing leukocyte protein of 76 kDa (SLP-76) following T-cell receptor ligation and Akt kinase phosphorylation in Jurkat cells, activating the phosphoinositide 3-hydroxykinase (PI3K) signaling cascade. PMID: 21282515
  35. Elevated expression of LAT1 is associated with squamous cell carcinoma of the lung. PMID: 19068093
  36. Results indicate for the first time that LAT promotes TCR signal initiation and suggest that this adapter may contribute to maintaining active Lck in proximity to their substrates. PMID: 21152094
  37. LAT ubiquitylation serves as a molecular checkpoint for attenuating T-cell signaling. PMID: 21282648
  38. These findings reveal a novel role for HSP90 as a positive regulator for the expression of the LAT gene in activated T cells. PMID: 21251717
  39. The adapter LAT contains several conserved serine-based motifs that are essential for proper signal transduction through the TCR. PMID: 20940326
  40. Studies suggest that LAT is present in membrane rafts and involved in signaling through various receptors besides the T cell receptor. PMID: 20875087
  41. A significant decrease in the mRNA expression of the LAT gene in T cells of asthmatic patients may be attributed to the up-regulation of its upstream regulatory factors Lck and ZAP-70. PMID: 18683785
  42. LAT displacement from lipid rafts is a molecular mechanism by which PUFAs inhibit T cell signaling. PMID: 12029091
  43. Phosphorylation of the linker for activation of T-cells by Itk promotes the recruitment of Vav. PMID: 12186560
  44. LAT plays a role in signal transduction for T cell activation and is stably associated with plasma membrane rafts. PMID: 12515827
  45. Interaction with the open-active form of Lck in lipid rafts reveals a new mechanism for regulating Lck in T cells. PMID: 12570875
  46. Examination of synergistic assembly in T cell plasma membrane domains. PMID: 12646565
  47. The T cell adapter molecule LAT is required for the correct orientation of the microtubule-organizing center as it moves toward the interface of the T cell and antigen-presenting cell. PMID: 12847255
  48. Results elucidate the basis for preferential recognition of specific LAT sites by Gads. PMID: 15029250
  49. CD3/T cell receptor complex signaling to beta 1 integrins is defective in LAT-deficient Jurkat T cells and can be restored with the expression of wild-type LAT. PMID: 15100278
  50. LAB resembles a LAT molecule unable to bind phospholipase C-gamma1. PMID: 15153499

Show More

Hide All

Database Links

HGNC: 18874

OMIM: 602354

KEGG: hsa:27040

UniGene: Hs.632179

Involvement In Disease
Immunodeficiency 52 (IMD52)
Subcellular Location
Cell membrane; Single-pass type III membrane protein. Note=Present in lipid rafts.
Tissue Specificity
Expressed in thymus, T-cells, NK cells, mast cells and, at lower levels, in spleen. Present in T-cells but not B-cells (at protein level).

Q&A

What is LAT and why is Y200 phosphorylation important in immunological research?

LAT (Linker for Activation of T-cells family member 1) is a critical adapter protein in immune cell signaling pathways. It contains a short extracellular region, a transmembrane domain, and a cytoplasmic region with multiple tyrosine residues that become phosphorylated upon cellular activation. These phosphorylated tyrosines serve as binding sites for SH2 domain-containing proteins, enabling the nucleation of signaling complexes essential for downstream immune responses .

The Y200 phosphorylation site represents one of the key regulatory nodes in LAT function. When phosphorylated, this site creates specific docking platforms for signaling effectors that propagate activation signals. Research has demonstrated that this phosphorylation event is significantly increased in response to specific immunological stimuli. For example, studies show that agonists like katacine can induce substantial increases (18.8 ± 5.9-fold) in LAT Y200 phosphorylation compared to baseline levels .

The significance of Y200 phosphorylation extends beyond simple protein modification – it represents a critical switch point in immune cell activation, integrating upstream signals from receptors and transmitting them to downstream effectors that drive cellular responses including cytokine production, proliferation, and effector functions .

How does LAT Y200 phosphorylation relate to other phosphorylation sites in the signaling pathway?

LAT Y200 phosphorylation operates within a complex network of coordinated phosphorylation events that collectively regulate immune cell activation. This phosphorylation site is primarily modified by Syk kinase, which itself must be activated through phosphorylation at its Y525/526 sites . Research demonstrates a clear correlation between these events, where inhibitors reducing Syk phosphorylation by 50-62% correspondingly reduced LAT Y200 phosphorylation by 52-74% .

The relationship between LAT Y200 and other LAT phosphorylation sites (such as Y132, Y171, Y191, and Y226) follows specific patterns depending on the stimulus and cell type. Each phosphorylation site recruits distinct effector proteins – for instance, PLC-γ1 binding to phosphorylated Y132, while Grb2 associates with phosphorylated Y171, Y191, and Y226 .

Downstream of LAT Y200 phosphorylation, several signaling proteins become activated, including PLCγ2 at Y1217. Studies reveal the proportional relationship between these events, with treatments reducing LAT Y200 phosphorylation by 74% leading to a 67% reduction in PLCγ2 phosphorylation . This demonstrates the sequential and quantitatively linked nature of this signaling cascade.

What distinguishes phospho-LAT (Y200) from phospho-LAT at other sites like Y220?

While both Y200 and Y220 phosphorylation sites occur on the same LAT protein, they exhibit distinct characteristics in terms of regulation, function, and detection methodologies. These sites are phosphorylated by overlapping but not identical kinases, potentially with different kinetics and thresholds for activation depending on stimulus strength and duration.

The phosphorylation at Y200 creates binding sites for specific SH2 domain-containing proteins that may differ from those binding to phosphorylated Y220. This difference in protein recruitment leads to divergent downstream signaling outcomes. Additionally, the antibodies used to detect these phosphorylation events are highly specific to each site – phospho-LAT (Y200) antibodies recognize the unique peptide sequence surrounding the Y200 residue, while phospho-LAT (Y220) antibodies target the distinct sequence context of Y220 .

From a methodological perspective, researchers must be careful to select the appropriate phospho-specific antibody for their experimental question. For example, when investigating T-cell receptor signaling, monitoring both sites may provide complementary information about the activation state of different signaling branches. The choice between monitoring Y200 or Y220 phosphorylation should be guided by which downstream pathways are most relevant to the research question.

What are the optimal protocols for detecting LAT Y200 phosphorylation in different experimental systems?

Detection of LAT Y200 phosphorylation requires carefully optimized protocols that preserve phosphorylation status while maximizing sensitivity. Western blotting represents the most common approach, employing phospho-specific antibodies that recognize the Y200 site. For optimal results, cells should be lysed in buffers containing strong phosphatase inhibitors (5mM sodium orthovanadate) and protease inhibitors (10 μg/mL aprotinin, 1 μg/mL pepstatin, 10 μg/mL leupeptin, 400 μg/mL AEBFS) .

For T-cell studies, stimulation with anti-CD3/CD28 antibodies provides reliable LAT phosphorylation. In platelet research, agonists like collagen, rhodocytin, or katacine at standardized concentrations (typically 100 nM for rhodocytin or 10 μM for katacine) effectively induce LAT phosphorylation . Time-course experiments should be implemented to capture the typically transient nature of this modification, with early timepoints (30 seconds to 5 minutes) often showing peak phosphorylation.

Immunoprecipitation followed by Western blotting offers enhanced sensitivity for detecting low-abundance phosphorylated LAT. This approach involves pre-clearing cell lysates with Protein A/G Sepharose, incubating with specific antibodies (typically 2 μg), capturing with Sepharose beads, and analyzing by SDS-PAGE and western blotting . ELISA-based methods provide quantitative alternatives when analyzing multiple samples simultaneously, particularly when standardized across experimental batches.

How can researchers optimize sample preparation to maximize phospho-LAT (Y200) detection sensitivity?

Maximizing detection sensitivity for phospho-LAT (Y200) requires meticulous attention to sample preparation. Cell stimulation protocols should be standardized with precise timing, as phosphorylation events are often transient. For platelets, studies typically use stirring at 1,200 rpm at 37°C for defined periods (e.g., 5 minutes) . The presence of eptifibatide (9 μM) during platelet stimulation prevents aggregation while preserving signaling events .

Cell lysis represents a critical step where phosphorylation status can be compromised. Rapid lysis at cold temperatures using buffers with high concentrations of phosphatase inhibitors is essential. For Western blotting applications, direct addition of hot SDS buffer (10% SDS, 0.5 M DTT, 50% glycerol, 0.125 M Tris) followed by immediate boiling (5 minutes at 100°C) effectively preserves phosphorylation status . For immunoprecipitation, NP-40 lysis buffers supplemented with comprehensive inhibitor cocktails yield optimal results .

Control samples should be processed in parallel, including positive controls (cells treated with known potent inducers of LAT phosphorylation) and vehicle controls to establish baseline phosphorylation levels. When blotting, membranes should be blocked with 5% BSA rather than milk (which contains phosphatases) and incubated with phospho-specific antibodies at optimized concentrations (typically 1:1000 dilution) .

What technical controls are essential when working with phospho-LAT (Y200) antibodies?

Implementing rigorous controls is crucial for reliable interpretation of phospho-LAT (Y200) results. Positive controls should include lysates from cells stimulated with established inducers - rhodocytin (100 nM) for platelets or anti-CD3/CD28 for T-cells - which typically induce 4-40 fold increases in Y200 phosphorylation compared to baseline . Negative controls must include unstimulated cells and vehicle-treated samples processed identically to experimental samples.

Phosphatase treatment controls are particularly important for validating antibody phospho-specificity. Parallel samples treated with lambda phosphatase should show elimination of the phospho-LAT signal while total LAT levels remain unchanged. This confirms that the antibody exclusively recognizes the phosphorylated form of the protein. Additionally, competitive blocking with phospho-LAT (Y200) peptide immunogen should progressively reduce specific signals, providing further validation of antibody specificity.

For quantitative analysis, normalization controls are essential. This includes probing for total LAT to normalize phospho-LAT signals, accounting for potential variations in total protein expression. Loading controls (β-actin, GAPDH) or alternative approaches like stain-free gel technology provide additional quality assurance. Time-course experiments serve as kinetic controls, ensuring that observations are made within the appropriate window of phosphorylation dynamics.

How can phospho-LAT (Y200) studies be integrated with analyses of other signaling components?

Integrating phospho-LAT (Y200) analysis with broader signaling studies provides contextual understanding of signaling networks. Multiple phosphorylation events can be examined simultaneously through sequential immunoblotting of the same membrane. After detection of phospho-LAT (Y200), membranes can be stripped and reprobed for other phosphorylated proteins like Syk (Y525/526), PLCγ2 (Y1217), or PKC substrates . This approach reveals the proportional relationships between these modifications, such as the observation that treatments reducing LAT Y200 phosphorylation by 52-74% lead to corresponding reductions in downstream phosphorylation events .

Multiplexed flow cytometry provides single-cell resolution of phosphorylation networks, enabling correlation of phospho-LAT (Y200) with other modifications and cellular markers. This approach is particularly valuable for analyzing heterogeneous populations like peripheral blood samples. For spatial information, microscopy techniques using differentially labeled antibodies against phospho-LAT (Y200) and binding partners reveal the subcellular organization of signaling complexes.

Pharmacological approaches using targeted inhibitors help establish causality within signaling networks. For example, studies with SMIH (HSP47 inhibitor) demonstrated dose-dependent inhibition of both upstream (Src, Lyn) and downstream (PLCγ2, PKC substrates) phosphorylation events relative to LAT Y200, confirming the sequential nature of this pathway . Genetic approaches using LAT mutations at specific tyrosine residues further dissect the functional significance of individual phosphorylation sites.

What are common sources of variability in phospho-LAT (Y200) detection and how can they be addressed?

Several factors contribute to variability in phospho-LAT (Y200) detection, requiring systematic troubleshooting approaches. Sample preparation variations represent a primary source of inconsistency. Standardizing cell stimulation protocols with precise timing, temperature, and reagent concentrations is essential. Research shows that even minor variations in stimulation conditions can significantly affect phosphorylation levels - for example, studies report rhodocytin (100 nM) typically induces 41.5 ± 4.5-fold increases in LAT Y200 phosphorylation, but this can vary based on experimental conditions .

Phosphatase activity during sample processing frequently undermines reproducibility. Implementing comprehensive phosphatase inhibition (5mM sodium orthovanadate, 10mM NaF) throughout all sample handling steps is critical. Lysis buffer composition directly impacts phosphorylation preservation - for example, direct addition of hot SDS buffer followed by immediate boiling substantially increases phospho-signal retention compared to milder lysis methods .

Antibody-related factors significantly influence results. Lot-to-lot variability in commercial antibodies can be addressed by purchasing larger lots for long-term studies and validating each new lot against previous standards. Storage conditions matter - antibodies should be aliquoted to avoid repeated freeze-thaw cycles, which can progressively reduce detection sensitivity. When quantifying results, ensuring signals remain within the linear detection range prevents underestimation of differences in highly phosphorylated samples.

How should researchers interpret changes in LAT Y200 phosphorylation in different experimental contexts?

Interpreting phospho-LAT (Y200) results requires careful consideration of both biological and technical contexts. Magnitude assessment is fundamental - robust stimuli typically induce multi-fold changes in phosphorylation. For example, rhodocytin (100 nM) induces approximately 41.5 ± 4.5-fold increases in LAT Y200 phosphorylation while katacine (10 μM) induces 18.8 ± 5.9-fold increases relative to baseline . Changes of smaller magnitude (1.5-2 fold) may be statistically significant but require careful validation to confirm biological relevance.

Temporal dynamics provide critical context. LAT phosphorylation typically follows rapid kinetics, often peaking within minutes of stimulation before returning to baseline. Single timepoint measurements may miss important features of these dynamics. Researchers should interpret phosphorylation changes within their temporal profile, ideally with reference to established kinetic patterns for their specific experimental system.

The relationship between phosphorylation and functional outcomes is rarely linear. Threshold effects often characterize signaling systems, where certain levels of phosphorylation must be achieved before downstream effects manifest. Studies have demonstrated corresponding relationships between LAT Y200 phosphorylation and downstream events - for example, treatments reducing LAT Y200 phosphorylation by 74% led to a 67% reduction in PLCγ2 phosphorylation and 85% reduction in PKC substrate phosphorylation . These proportional relationships help establish functional significance.

What approaches can distinguish specific from non-specific signals in phospho-LAT (Y200) experiments?

Distinguishing specific from non-specific signals requires systematic validation approaches. Molecular weight verification represents the first level of validation - LAT typically appears at approximately 36-40 kDa on Western blots . Bands appearing at substantially different molecular weights likely represent non-specific binding.

Phosphatase treatment provides a definitive specificity control. Treatment of duplicate samples with lambda phosphatase should eliminate genuine phospho-LAT (Y200) signals while non-specific bands remain largely unaffected. This approach conclusively demonstrates that the observed signal depends on phosphorylation status rather than non-specific antibody binding.

Stimulus-response patterns offer additional validation. Phospho-LAT (Y200) signals should increase appropriately with stimulation in a dose-dependent manner. Studies demonstrate that true phospho-LAT signals show substantial fold-changes following appropriate stimulation - for example, rhodocytin induces approximately 41.5 ± 4.5-fold increases while katacine induces 18.8 ± 5.9-fold increases in phosphorylation . Signals that don't respond appropriately to stimulation may represent non-specific binding.

Peptide competition assays provide further confirmation of specificity. Pre-incubating the phospho-LAT (Y200) antibody with increasing concentrations of the specific phospho-peptide immunogen should progressively reduce or eliminate genuine signals while non-specific binding remains largely unaffected. This approach directly tests the binding specificity of the antibody for its intended target.

How can researchers investigate the dynamics of LAT oligomerization and its relationship to Y200 phosphorylation?

Investigating LAT oligomerization dynamics requires specialized techniques that probe molecular interactions with high spatial and temporal resolution. Super-resolution microscopy approaches have revealed that LAT forms nanoscale clusters in the plasma membrane, with phosphorylation status - particularly at sites like Y200 - influencing the stability and composition of these structures . These techniques overcome the diffraction limit of conventional microscopy, enabling visualization of LAT organization at 10-20 nm resolution.

Biochemical approaches provide complementary insights into LAT oligomerization. Blue native PAGE can separate protein complexes in their native state, revealing the heterogeneity of LAT-containing assemblies. Chemical crosslinking followed by immunoprecipitation and mass spectrometry identifies the composition of these complexes and how they change with phosphorylation status. Studies have demonstrated that phosphorylated LAT serves as a platform for the assembly of multiprotein complexes through cooperative interactions .

The relationship between Y200 phosphorylation and oligomerization can be investigated through site-directed mutagenesis approaches. Comparing wild-type LAT with Y200F mutants (preventing phosphorylation at this site) reveals the specific contribution of this modification to complex formation. FRET-based approaches using differentially labeled LAT molecules provide dynamic readouts of oligomerization in living cells, revealing how stimulation-induced Y200 phosphorylation correlates with changes in FRET efficiency indicating altered molecular proximity.

What methodologies enable quantitative analysis of LAT Y200 phosphorylation kinetics?

Quantitative analysis of LAT Y200 phosphorylation kinetics requires methodologies with high temporal resolution and precise quantification. Time-resolved western blotting with multiple early timepoints (15s, 30s, 1min, 2min, 5min) captures both the rise and decay phases of phosphorylation. Studies implementing this approach have demonstrated that LAT Y200 phosphorylation typically peaks within minutes of stimulation, with specific kinetics depending on stimulus strength and cell type . Quantification of phospho-LAT (Y200)/total LAT ratios at each timepoint followed by mathematical modeling (exponential rise/decay functions) extracts key kinetic parameters.

Phospho-flow cytometry offers single-cell resolution of phosphorylation kinetics. This approach involves paraformaldehyde fixation at precise timepoints to preserve phosphorylation status, followed by permeabilization and staining with fluorochrome-conjugated phospho-LAT (Y200) antibodies. The resulting data can be analyzed using kinetic modeling software to extract rate constants and identify potential heterogeneity in cellular responses that might be masked in population-average measurements.

Inhibitor wash-in/wash-out studies provide mechanistic insights into the regulation of LAT Y200 phosphorylation. Rapid application and removal of kinase inhibitors (targeting Syk or Src-family kinases) or phosphatase inhibitors reveals how quickly Y200 phosphorylation responds to these perturbations. Studies employing this approach have demonstrated that treatments targeting upstream kinases like Syk rapidly reduce LAT Y200 phosphorylation, confirming the dynamic nature of this modification .

How do emerging single-molecule techniques advance our understanding of LAT signaling complexes?

Emerging single-molecule techniques are revolutionizing our understanding of LAT signaling by revealing previously inaccessible aspects of molecular organization and dynamics. Single-molecule localization microscopy (SMLM) techniques like PALM and STORM achieve 10-20 nm spatial resolution, sufficient to resolve individual LAT molecules and their organization into signaling clusters. These approaches have revealed that LAT forms distinct nanoscale assemblies upon cell activation, with phosphorylation at sites like Y200 influencing cluster formation and stability .

Single-particle tracking (SPT) monitors the movement of individual LAT molecules in living cells, revealing how mobility changes upon phosphorylation. This technique has demonstrated that LAT molecules exhibit distinct diffusion behaviors before and after receptor engagement, with phosphorylation events including Y200 modification correlating with altered mobility patterns. These mobility changes reflect the incorporation of LAT into larger signaling complexes mediated by interactions through phosphorylated tyrosine residues.

Live-cell single-molecule FRET detects direct protein-protein interactions at the molecular level, revealing the dynamics of LAT complex assembly and disassembly. This approach has shown that phosphorylation at sites like Y200 creates binding interfaces for SH2 domain-containing proteins, with interaction kinetics that can be quantitatively measured. The resulting data provides unprecedented insights into the temporal sequence of protein recruitment to LAT following phosphorylation events.

How can systems biology approaches integrate phospho-LAT (Y200) data into comprehensive signaling models?

Systems biology approaches offer powerful frameworks for integrating phospho-LAT (Y200) data into comprehensive signaling models. Mathematical modeling using ordinary differential equations (ODEs) can represent the kinetics of LAT phosphorylation within broader signaling networks. These models incorporate multiple phosphorylation sites, feedback loops, and the cooperative interactions that characterize LAT signaling. Studies have demonstrated that such models can accurately predict how perturbations at one point in the network (e.g., inhibition of upstream kinases) propagate to affect multiple downstream events in quantitatively predictable ways .

Network analysis approaches reveal the topological features of LAT-centered signaling. By integrating phosphoproteomic data from multiple timepoints and experimental conditions, researchers can construct directed graphs representing information flow through the network. This approach has identified LAT as a critical node linking receptor activation to downstream effector pathways, with Y200 phosphorylation serving as a key regulatory point with high network centrality.

Computational modeling of protein-protein interactions provides molecular-level insights into how Y200 phosphorylation facilitates complex formation. Molecular dynamics simulations reveal conformational changes induced by phosphorylation that create binding interfaces for SH2 domain-containing proteins. These simulations predict binding energetics and kinetics that can be experimentally validated, creating an iterative cycle between computational prediction and experimental verification that progressively refines our understanding of LAT signaling dynamics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.